Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease

Efferocytosis is defined as the clearance of apoptotic cells (ACs) in physiological and pathological states and is performed by efferocytes, such as macrophages. Efferocytosis can lead to the resolution of inflammation and restore tissue homoeostasis; however, the mechanisms of efferocytosis in determining inflammation resolution are still not completely understood, and the effects of efferocytosis on other proresolving properties need to be explored and explained. In this review, the process of efferocytosis will be summarized briefly, and then these mechanisms and effects will be thoroughly discussed. In addition, the association between mechanisms of efferocytosis in determining resolution of inflammation and cardiovascular diseases will also be reviewed, as an understanding of this association may provide information on novel treatment targets.

[1]  Qintao Wang,et al.  Apoptotic extracellular vesicles alleviate Pg-LPS induced inflammation of macrophages via AMPK/SIRT1/NF-κB pathway and inhibit adjacent osteoclasts formation. , 2022, Journal of periodontology.

[2]  Wenli Zhang,et al.  Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis. , 2022, Carbohydrate polymers.

[3]  J. Michel,et al.  The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice. , 2022, Biochemical pharmacology.

[4]  A. Sun,et al.  Cardiac Resident Macrophage-Derived Legumain Improves Cardiac Repair by Promoting Clearance and Degradation of Apoptotic Cardiomyocytes After Myocardial Infarction , 2022, Circulation.

[5]  Madankumar Ghatge,et al.  Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis , 2022, Circulation research.

[6]  D. Perrais,et al.  Live cell tracking of macrophage efferocytosis during Drosophila embryo development in vivo , 2022, Science.

[7]  Qian Zhang,et al.  Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis , 2022, Frontiers in Cardiovascular Medicine.

[8]  A. Tall,et al.  Macrophages Use Apoptotic Cell-Derived Methionine and DNMT3A During Efferocytosis to Promote Tissue Resolution , 2022, Nature Metabolism.

[9]  S. Tugtekin,et al.  Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation , 2022, The Journal of clinical investigation.

[10]  Ajit S. Divakaruni,et al.  Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair , 2022, Cellular and molecular gastroenterology and hepatology.

[11]  P. Saas,et al.  Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease , 2021, Frontiers in Immunology.

[12]  M. Teixeira,et al.  Angiotensin-(1-7)/MasR axis promotes migration of monocytes/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis , 2021, JCI insight.

[13]  N. Leeper,et al.  Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis—Brief Report , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Na Kong,et al.  Efferocytosis induces macrophage proliferation to help resolve tissue injury. , 2021, Cell metabolism.

[15]  Stephen P. H. Alexander,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors , 2021, British journal of pharmacology.

[16]  Stephen P. H. Alexander,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets , 2021, British journal of pharmacology.

[17]  Stephen P. H. Alexander,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors , 2021, British journal of pharmacology.

[18]  Maxim N. Artyomov,et al.  Non-canonical glutamine transamination sustains efferocytosis by coupling redox buffering to oxidative phosphorylation , 2021, Nature Metabolism.

[19]  Byung-Soo Kim,et al.  Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function. , 2021, Acta biomaterialia.

[20]  J. Korostoff,et al.  Stromal cell-derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis. , 2021, The Journal of clinical investigation.

[21]  R. Tian,et al.  Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution , 2021, Bioactive materials.

[22]  R. Baumgartner,et al.  The resolvin D1 receptor GPR32 transduces inflammation-resolution and atheroprotection. , 2021, The Journal of clinical investigation.

[23]  Wenhua Yu,et al.  MerTK inhibits the activation of the NLRP3 inflammasome after subarachnoid hemorrhage by inducing autophagy , 2021, Brain Research.

[24]  F. Amaral,et al.  Resolving inflammation by TAM receptor activation. , 2021, Pharmacology & therapeutics.

[25]  Jun Pu,et al.  Protective Functions of Liver X Receptor α in Established Vulnerable Plaques: Involvement of Regulating Endoplasmic Reticulum–Mediated Macrophage Apoptosis and Efferocytosis , 2021, Journal of the American Heart Association.

[26]  B. Brüne,et al.  Lysosome-Dependent LXR and PPARδ Activation Upon Efferocytosis in Human Macrophages , 2021, Frontiers in Immunology.

[27]  Yan Jin,et al.  Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes , 2021, Journal of extracellular vesicles.

[28]  B. Heit,et al.  Cellular Responses to the Efferocytosis of Apoptotic Cells , 2021, Frontiers in Immunology.

[29]  A. A. Maksimova,et al.  Efferocytosis Modulates Arginase-1 and Tyrosine Kinase Mer Expression in GM-CSF-Differentiated Human Macrophages , 2021, Bulletin of Experimental Biology and Medicine.

[30]  Kelly V. Ruggles,et al.  Wnt signaling enhances macrophage responses to IL-4 and promotes resolution of atherosclerosis , 2021, eLife.

[31]  R. Yates,et al.  Better Together: Current Insights Into Phagosome-Lysosome Fusion , 2021, Frontiers in Immunology.

[32]  Wei Tao,et al.  ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution. , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[33]  M. Sergeeva,et al.  Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes , 2020, International journal of molecular sciences.

[34]  A. Maimon,et al.  Corrigendum: Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming , 2020, Frontiers in Immunology.

[35]  B. Brüne,et al.  Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation , 2020, Cell Death & Differentiation.

[36]  V. De Rosa,et al.  The DEL-1-β3 integrin axis promotes regulatory T cell responses during inflammation resolution. , 2020, The Journal of clinical investigation.

[37]  S. Hodge,et al.  LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness , 2020, Frontiers in Oncology.

[38]  O. Farokhzad,et al.  siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice , 2020, Science Translational Medicine.

[39]  V. de Waard,et al.  S100A9 Links Inflammation and Repair in Myocardial Infarction , 2020, Circulation research.

[40]  M. Wurfel,et al.  Cholesterol-25-hydroxylase promotes efferocytosis and resolution of lung inflammation. , 2020, JCI insight.

[41]  K. Moore,et al.  Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression , 2020, Circulation research.

[42]  J. Wan,et al.  LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling , 2020, Science Translational Medicine.

[43]  D. Green,et al.  The clearance of dead cells by efferocytosis , 2020, Nature Reviews Molecular Cell Biology.

[44]  D. Gilroy,et al.  Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly , 2020, Nature Immunology.

[45]  L. Suggs,et al.  Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle. , 2020, Acta biomaterialia.

[46]  Xuefei Shen,et al.  Resolvin D1 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Increasing Treg Percentages via the ALX/FPR2 Pathway , 2020, Frontiers in Physiology.

[47]  G. Hajishengallis,et al.  Phagocytosis of Apoptotic Cells in Resolution of Inflammation , 2020, Frontiers in Immunology.

[48]  Dave Singh,et al.  Effects of Corticosteroids on COPD Lung Macrophage Phenotype and Function. , 2020, Clinical science.

[49]  Yitao Wang,et al.  PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation , 2020, Autophagy.

[50]  Y. Takei,et al.  Protein S protects against allergic bronchial asthma by modulating Th1/Th2 balance , 2020, Allergy.

[51]  Cholesterol 25-Hydroxylase , 2020, Definitions.

[52]  Scott B. Crown,et al.  Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury. , 2020, Cell metabolism.

[53]  M. Teixeira,et al.  Cyclic AMP Regulates Key Features of Macrophages via PKA: Recruitment, Reprogramming and Efferocytosis , 2020, Cells.

[54]  Xiaojing Ma,et al.  Isolation and Stimulation of Peritoneal Macrophages withApoptotic Jurkat Cells to Produce IL-10. , 2019, Bio-protocol.

[55]  I. Tabas,et al.  Efferocytosis in health and disease , 2019, Nature Reviews Immunology.

[56]  E. Marbán,et al.  Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[57]  Rachel E. Brewer,et al.  CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy , 2019, Nature.

[58]  C. Reutelingsperger,et al.  Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair. , 2019, Journal of the American College of Cardiology.

[59]  J. Walsh,et al.  Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction , 2019, Front. Pharmacol..

[60]  D. Green,et al.  LC3-associated phagocytosis at a glance , 2019, Journal of Cell Science.

[61]  I. Ben-Sahra,et al.  Efferocytosis Fuels Requirements of Fatty Acid Oxidation and the Electron Transport Chain to Polarize Macrophages for Tissue Repair. , 2019, Cell metabolism.

[62]  L. Mao,et al.  LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation , 2019, Cell Death & Disease.

[63]  A. Tajbakhsh,et al.  Effect of soluble cleavage products of important receptors/ligands on efferocytosis: Their role in inflammatory, autoimmune and cardiovascular disease , 2019, Ageing Research Reviews.

[64]  P. Galuppo,et al.  Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing , 2018, Hypertension.

[65]  R. Baumgartner,et al.  ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages , 2018, Circulation.

[66]  G. Gusarova,et al.  Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution , 2018, Immunity.

[67]  Hong Jin,et al.  Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque , 2018, Theranostics.

[68]  L. Joosten,et al.  DEL-1 promotes macrophage efferocytosis and clearance of inflammation , 2018, Nature Immunology.

[69]  R. Birge,et al.  MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity , 2018, Science Signaling.

[70]  M. Cooper,et al.  Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis , 2018, Diabetes.

[71]  Y. Rikihisa,et al.  Ehrlichia type IV secretion system effector Etf-2 binds to active RAB5 and delays endosome maturation , 2018, Proceedings of the National Academy of Sciences.

[72]  L. C. Spolidorio,et al.  Intestinal host defense outcome is dictated by PGE2 production during efferocytosis of infected cells , 2018, Proceedings of the National Academy of Sciences.

[73]  C. Ungermann,et al.  Multisubunit tethers in membrane fusion , 2018, Current Biology.

[74]  M. Munson,et al.  SNARE complex assembly and disassembly , 2018, Current Biology.

[75]  K. Hovingh,et al.  Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production , 2018, Circulation research.

[76]  A. Maimon,et al.  Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming , 2018, Front. Immunol..

[77]  Clint L. Miller,et al.  Proefferocytic Therapy Promotes Transforming Growth Factor-β Signaling and Prevents Aneurysm Formation. , 2018, Circulation.

[78]  P. Kovanen,et al.  Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms , 2018, Pharmacology & therapeutics.

[79]  F. Dell’Accio,et al.  Neutrophil Microvesicles from Healthy Control and Rheumatoid Arthritis Patients Prevent the Inflammatory Activation of Macrophages , 2018, EBioMedicine.

[80]  M. Teixeira,et al.  Angiotensin-(1–7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma , 2018, Front. Immunol..

[81]  B. Levy,et al.  PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo , 2017, Science Advances.

[82]  J. C. Love,et al.  Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage , 2017, The Journal of clinical investigation.

[83]  G. Fredman,et al.  Specialized pro-resolving mediators in cardiovascular diseases. , 2017, Molecular aspects of medicine.

[84]  M. Teixeira,et al.  Angiotensin-(1-7) Promotes Resolution of Neutrophilic Inflammation in a Model of Antigen-Induced Arthritis in Mice , 2017, Front. Immunol..

[85]  A. Tall,et al.  CAMKII&ggr; suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis , 2017, The Journal of clinical investigation.

[86]  Daniel C. Lee,et al.  MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury , 2017, Circulation research.

[87]  Michael R. Elliott,et al.  Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses , 2017, The Journal of Immunology.

[88]  R. Touyz,et al.  Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis , 2017, British journal of pharmacology.

[89]  M. Daemen,et al.  MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis , 2017, The Journal of clinical investigation.

[90]  Tamás Röszer.  Transcriptional control of apoptotic cell clearance by macrophage nuclear receptors , 2016, Apoptosis.

[91]  A. Orekhov,et al.  Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis. , 2017, Current pharmaceutical design.

[92]  M. Perretti,et al.  Neutrophils induce proangiogenic T cells with a regulatory phenotype in pregnancy , 2016, Proceedings of the National Academy of Sciences.

[93]  A. Yoshimura,et al.  Induced Regulatory T Cells: Their Development, Stability, and Applications. , 2016, Trends in immunology.

[94]  Tamás Röszer.  Transcriptional control of apoptotic cell clearance by macrophage nuclear receptors , 2016, Apoptosis.

[95]  L. Battistini,et al.  Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses , 2016, Science Translational Medicine.

[96]  E. Chaikof,et al.  Efferocytosis as a regulator of macrophage chemokine receptor expression and polarization , 2016, European journal of immunology.

[97]  G. Fredman,et al.  MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation , 2016, Proceedings of the National Academy of Sciences.

[98]  B. Fleischmann,et al.  Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor , 2016, Circulation.

[99]  K. Ravichandran,et al.  Do not let death do us part: ‘find-me’ signals in communication between dying cells and the phagocytes , 2016, Cell Death and Differentiation.

[100]  S. Fuller,et al.  IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1 , 2015, The Journal of Immunology.

[101]  A. Berger,et al.  The role of C1q in recognition of apoptotic epithelial cells and inflammatory cytokine production by phagocytes during Helicobacter pylori infection , 2015, Journal of Inflammation.

[102]  D. Green,et al.  Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins , 2015, Nature Cell Biology.

[103]  Beth S. Lee,et al.  Vacuolar ATPase in Phagosome-Lysosome Fusion , 2015, The Journal of Biological Chemistry.

[104]  M. Perretti,et al.  Biased Agonism as a Novel Strategy To Harness the Proresolving Properties of Melanocortin Receptors without Eliciting Melanogenic Effects , 2015, The Journal of Immunology.

[105]  D. Mevorach,et al.  Apoptotic Cells Induce NF-κB and Inflammasome Negative Signaling , 2015, PloS one.

[106]  O. Farokhzad,et al.  Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice , 2015, Science Translational Medicine.

[107]  Jeesun Lim,et al.  PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines , 2015, Mucosal Immunology.

[108]  C. López-Otín,et al.  The functional and pathologic relevance of autophagy proteases. , 2015, The Journal of clinical investigation.

[109]  W. Boisvert,et al.  Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function , 2014, Thrombosis and Haemostasis.

[110]  M. Idzko,et al.  Nucleotide signalling during inflammation , 2014, Nature.

[111]  T. Poll,et al.  TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis , 2014 .

[112]  C. Münz,et al.  LC3-associated phagocytosis , 2014, Autophagy.

[113]  M. Dinauer,et al.  Regulation of the NADPH Oxidase and Associated Ion Fluxes During Phagocytosis , 2013, Traffic.

[114]  Janet S. Lee,et al.  Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury , 2013, Mucosal Immunology.

[115]  H. Horvitz,et al.  Xk-Related Protein 8 and CED-8 Promote Phosphatidylserine Exposure in Apoptotic Cells , 2013, Science.

[116]  A. Brunger,et al.  Disassembly of All SNARE Complexes by N-Ethylmaleimide-sensitive Factor (NSF) Is Initiated by a Conserved 1:1 Interaction between α-Soluble NSF Attachment Protein (SNAP) and SNARE Complex* , 2013, The Journal of Biological Chemistry.

[117]  S. Homma,et al.  Enhanced Efferocytosis of Apoptotic Cardiomyocytes Through Myeloid-Epithelial-Reproductive Tyrosine Kinase Links Acute Inflammation Resolution to Cardiac Repair After Infarction , 2013, Circulation research.

[118]  W. Wood,et al.  SCAR/WAVE-mediated processing of engulfed apoptotic corpses is essential for effective macrophage migration in Drosophila , 2013, Cell Death and Differentiation.

[119]  Guowang Xu,et al.  Release of lysophospholipid ‘find-me’ signals during apoptosis requires the ATP-binding cassette transporter A1 , 2012, Autoimmunity.

[120]  V. Fuster,et al.  Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. , 2012, JACC. Cardiovascular imaging.

[121]  S. Nielsen,et al.  The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. , 2011, The American journal of pathology.

[122]  H. Kubo,et al.  Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells , 2011, EMBO reports.

[123]  U. Rescher,et al.  Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling , 2011, EMBO molecular medicine.

[124]  Michael R. Elliott,et al.  Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis , 2010, Nature.

[125]  Peter Tontonoz,et al.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. , 2009, Immunity.

[126]  R. Nibbs,et al.  CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. , 2008, Blood.

[127]  S. Milstien,et al.  Apoptosis induces expression of sphingosine kinase 1 to release sphingosine‐1‐phosphate as a “come‐and‐get‐me” signal , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[128]  M. Hengartner,et al.  A pathway for phagosome maturation during engulfment of apoptotic cells , 2008, Nature Cell Biology.

[129]  K. Herold,et al.  Receptor for Advanced Glycation End Products , 2008, Annals of the New York Academy of Sciences.

[130]  Li V. Yang,et al.  Migration to Apoptotic “Find-me” Signals Is Mediated via the Phagocyte Receptor G2A* , 2008, Journal of Biological Chemistry.

[131]  A. Schroit,et al.  Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. , 2008, The Journal of biological chemistry.

[132]  K. Ravichandran,et al.  Engulfment of apoptotic cells: signals for a good meal , 2007, Nature Reviews Immunology.

[133]  M. Perretti,et al.  Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities. , 2007, Journal of medicinal chemistry.

[134]  G. Cagney,et al.  Annexin-1 and Peptide Derivatives Are Released by Apoptotic Cells and Stimulate Phagocytosis of Apoptotic Neutrophils by Macrophages1 , 2007, The Journal of Immunology.

[135]  Stanley L. Hazen,et al.  Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells , 2006, The Journal of experimental medicine.

[136]  T. Cover,et al.  The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments. , 2005, Molecular biology of the cell.

[137]  P. Gasque,et al.  CD46 Plays a Key Role in Tailoring Innate Immune Recognition of Apoptotic and Necrotic Cells* , 2005, Journal of Biological Chemistry.

[138]  M. Perretti,et al.  Modulation of Phagocytosis of Apoptotic Neutrophils by Supernatant from Dexamethasone-Treated Macrophages and Annexin-Derived Peptide Ac2–261 , 2005, The Journal of Immunology.

[139]  S. Grinstein,et al.  Phagosomes Fuse with Late Endosomes and/or Lysosomes by Extension of Membrane Protrusions along Microtubules: Role of Rab7 and RILP , 2003, Molecular and Cellular Biology.

[140]  S. Baksh,et al.  Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal , 2003, Cell.

[141]  N. Brot,et al.  I-PLA2 Activation during Apoptosis Promotes the Exposure of Membrane Lysophosphatidylcholine Leading to Binding by Natural Immunoglobulin M Antibodies and Complement Activation , 2002, The Journal of experimental medicine.

[142]  Gerald R. Fink,et al.  Unconventional Rac-GEF activity is mediated through the Dock180–ELMO complex , 2002, Nature Cell Biology.

[143]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[144]  Hugh R. Brady,et al.  Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages1 , 2000, The Journal of Immunology.

[145]  J. M. Cousin,et al.  Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. , 1999, Journal of immunology.

[146]  G. Bokoch,et al.  Requirements for Both Rac1 and Cdc42 in Membrane Ruffling and Phagocytosis in Leukocytes , 1997, The Journal of experimental medicine.

[147]  I. Weissman,et al.  Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy , 2017, Nature Immunology.

[148]  R. Goldschmeding,et al.  Lipoxin A 4 and benzo-lipoxin A 4 attenuate experimental renal fibrosis , 2011 .

[149]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[150]  Peter J. Schaap,et al.  Molecular characterization of the , 1997 .